Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells <i>in vitro</i> and <i>in vivo</i>

Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Proceedings of the National Academy of Sciences Unpaywall

Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells <i>in vitro</i> and <i>in vivo</i>

Proceedings of the National Academy of SciencesAug 28, 2001

Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells <i>in vitro</i> and <i>in vivo</i>

Proceedings of the National Academy of SciencesAug 28, 2001

Loading next page...
 
/lp/unpaywall/linking-molecular-therapeutics-to-molecular-diagnostics-inhibition-of-N2wtqUCU5v

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0027-8424
DOI
10.1073/pnas.191379498
Publisher site
See Article on Publisher Site

Abstract

Journal

Proceedings of the National Academy of SciencesUnpaywall

Published: Aug 28, 2001

There are no references for this article.